Hepatitis C

The purpose of this case study on Hepatitis C (HCV) is to come up with a process improvement plan of getting patients screened, approved, educated, and started on treatment within a 20 day period. In order to make this happen, everyone in the clinic needs to be educated on the required clinical screenings and documentation. The case study is designed for: medical assistants, pre, post, tumor, and organ management nurses, and nurse practitioners. The case study will be reviewed over the next two

human blood that is caused by bacteria leading to harmful diseases and viruses. Bloodborne pathogens are spread through direct or indirect contact, and respiratory or vector borne transmission. Hepatitis C is a disease of the liver that is contagious and over time can cause other harmful problems. Hepatitis C starts off as an acute infection that in many cases can become chronic if not treated right away. Medical professionals work with needles and other sharp objects that come into contact with other

Main problem: Chronic Hepatitis C Hepatitis is a systemic disease primarily involving the liver, the term is used to construe inflammation of the liver. One of the main forms of Hepatitis is Hepatitis C; an RNA virus and uses liver cells to create copies of itself, killing those cells in the process. Prior to the identification of the infection in 1989 it was labelled “non-A, non-B” hepatitis (1). HCV blood-borne virus that predominantly infects the cells of the liver and advances to liver inflammation

The increasing number of citizens that are testing positive for Hepatitis C is shocking and the epidemic is just getting worse. One out of every one hundred people in the general population has Hepatitis C, but the ratio is higher in prisons. One out of every six inmates has Hepatitis C (Wegner, Rottnek, Parker and Crippin, 2014). Hepatitis C (HCV) is a blood disease that is caused by a virus and it affects the liver. Unfortunately there is no vaccine to prevent this disease and I have seen first-hand

Introduction The hepatitis C virus (HCV) is the most widespread blood borne infection throughout the United States. It is estimated that nearly 3.2 million Americans are chronically infected (Centers for Disease Control and Prevention, 2014). HCV is a leading cause of cirrhosis, hepatocellular carcinoma, and is an indication for liver transplant (Medscape, 2012). As a result, HCV poses a significant economic burden on the American health care system. For decades drugs given to cure HCV patients

Hepatitis Affection “Ignorance is bliss” and “knowledge is power,” two sayings that are used frequently. Yet, if you are in the medical field, it is risky to lay lives down, including your own, for an ‘I didn’t know.’ There are several reasons why I chose Hepatitis C for my research paper, but the main reason is Hepatitis C and Cirrhosis took a very special life away from me due to ignorance. With the medical field evolving everyday, there are some medical professionals that have conservative points-of-view

Risk factors and transmission: Hepatitis C infection is transmitted mainly through percutaneous exposure: injecting drug use, accidently needlestick injuries (Tohme and Holmberg, 2010), and procedures as renal dialysis and unscreened blood transfusions (Candotti et al., 2001), the latter has become rare due to routine screening for HCV (Boesecke, 2011). Most HCV infections occur in people who use unsterile injection and contaminated drug solutions (Nelson et al., 2011)

Hepatitis C has been referred to as a "Silent Epidemic," since it usually progresses slowly over many years. Most people who are infected with hepatitis C are not aware of any noticeable symptoms for as long as one to two decades after they are infected. In fact, by the time symptoms appear, the virus has probably already begun to damage the liver. If the liver is injured and stops functioning, death will always be the outcome (Lieber). Liver failure from chronic hepatitis C is one of the

Hepatitis C is a blood-borne pathogen that is expected to cause over 190,000 deaths between 2010 and 2019.1 HIV is about 5 times less common than hepatitis C virus (HCV) and in 2007 deaths due to HCV surpassed those due to HIV. The infection is more common in populations of high-risk (the homeless and prisoners) who predominantly do not participate in surveys, therefor the number infected with HCV is actually higher than reported. There are a number of risk factors for the infection, but injection-drug

Hepatitis C is a liver infection caused by the Hepatitis C virus (HCV). Hepatitis C is a blood-borne virus. Today, most people become infected with the Hepatitis C virus by sharing needles or other equipment to inject drugs. For some people, hepatitis C is a short-term illness but for 70%–85% of people who become infected with Hepatitis C, it becomes a long-term, chronic infection. Chronic Hepatitis C is a serious disease than can result in long-term health problems, even death. The majority of infected